CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-12 | Goldberg Andrew D. Director | Grant or award · Restricted Stock Units | +2,954 | 2,954 | ||
| 2025-06-12 | YARNO WENDY L Director | Grant or award · Stock Option (right to buy) | +4,540 | 4,540 | ||
| 2025-06-12 | YARNO WENDY L Director | Grant or award · Restricted Stock Units | +2,954 | 2,954 | ||
| 2025-06-12 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +4,540 | 4,540 | ||
| 2025-06-12 | Morrison Scott W Director | Grant or award · Restricted Stock Units | +2,954 | 2,954 | ||
| 2025-06-12 | LINK WILLIAM J PHD Director | Grant or award · Stock Option (right to buy) | +4,540 | 4,540 | ||
| 2025-06-12 | LINK WILLIAM J PHD Director | Grant or award · Restricted Stock Units | +2,954 | 2,954 | ||
| 2025-06-09 | Mottiwala Aziz Chief Commercial Officer | Sale 10b5-1 | −17,500 | $43.76 | $766K | 47,557 |
| 2025-03-24 | Azamian Bobak R. President/CEO and Board Chair | Sale | −6,000 | $50.00 | $300K | 824,106 |
| 2025-03-20 | Mottiwala Aziz Chief Commercial Officer | Sale | −3,365 | $50.11 | $169K | 65,057 |
| 2025-03-20 | Neervannan Seshadri Chief Operating Officer | Sale | −2,435 | $50.11 | $122K | 79,682 |
| 2025-03-20 | Wahl Bryan General Counsel | Sale | −3,084 | $50.11 | $155K | 51,712 |
| 2025-03-20 | Whitfield Dianne C. Chief Human Resources Officer | Sale | −2,137 | $50.11 | $107K | 46,355 |
| 2025-03-20 | Azamian Bobak R. President/CEO and Board Chair | Sale | −8,534 | $50.11 | $428K | 53,635 |
| 2025-03-20 | Farrow Jeffrey S See Remarks | Sale | −1,186 | $50.11 | $59K | 22,431 |
| 2025-03-19 | Mottiwala Aziz Chief Commercial Officer | Sale | −3,557 | $47.40 | $169K | 68,422 |
| 2025-03-19 | Neervannan Seshadri Chief Operating Officer | Sale | −2,543 | $47.40 | $121K | 82,117 |
| 2025-03-19 | Wahl Bryan General Counsel | Sale | −3,261 | $47.40 | $155K | 54,796 |
| 2025-03-19 | Whitfield Dianne C. Chief Human Resources Officer | Sale | −2,259 | $47.40 | $107K | 48,492 |
| 2025-03-19 | Azamian Bobak R. President/CEO and Board Chair | Sale | −8,551 | $47.40 | $405K | 62,169 |
Page 10 of 13 · 257 trades